Explorer les evidences

68,1 %Awareness of cervical cancer screening was 68.1% among women of a Catholic Parish in Nsukka Local Government Area of Enugu State, Nigeria.

Nigeriacancer du col de l'utéruspublié 2021The Pan African medical journalPubMeddocument de 8 observations

Cervical cancer is the second leading cause of cancer morbidity and mortality in Nigeria.

Nigeriacancer du col de l'utéruspublié 2022Cancer reports (Hoboken, N.J.)PubMeddocument de 4 observations

0,953 odds_ratioIncreasing age was an independent predictor of lower brachytherapy utilization (p = 0.005, OR = 0.953, 95% CI = 0.921–0.986).

Nigeriacancer du col de l'utérusobservé March 2021 to June 2024PubMeddocument de 6 observations

Cervical cancer is the second highest cancer among women in Nigeria.

Nigeriacancer du col de l'utéruspublié 2019Nigerian journal of clinical practicePubMeddocument de 7 observations

Cervical cancer remains a significant public health issue in low- and middle-income countries, especially in Western sub-Saharan Africa and Nigeria.

Nigeriacancer du col de l'utéruspublié 2025International journal of cancerPubMeddocument de 3 observations

3 per_10In a rural community in Enugu State, Nigeria, only 3 out of every 10 women were aware of cervical cancer and its preventive measures.

Nigeriacancer du col de l'utéruspublié 2026Rural and remote healthPubMeddocument de 8 observations

0,6 %Only two respondents (0.6%) had undergone cervical cancer screening.

Nigeriacancer du col de l'utéruspublié 2022West African journal of medicinePubMeddocument de 13 observations

173 patientsAmong 343 cervical cancer patients, 173 (50.43%) received brachytherapy.

Nigeriacancer du col de l'utérusobservé March 2021 to June 2024PubMeddocument de 6 observations

45,2 %Only 45.2% of women in Taraba, North-East Nigeria regularly engaged in cervical cancer screening and other prevention practices.

Nigeriacancer du col de l'utéruspublié 2019Asian Pacific journal of cancer prevention : APJCPPubMeddocument de 6 observations

87,4 %87.4% of the respondents had not accompanied their wife/female partner for cervical cancer screening.

Nigeriacancer du col de l'utérusobservé 2018publié 2023PloS onePubMeddocument de 14 observations

28,8 %Cervical cancer awareness was low at 28.8% among women aged 25 to 65 years in Makurdi, North-Central Nigeria.

Nigeriacancer du col de l'utéruspublié 2025Asian Pacific journal of cancer prevention : APJCPPubMeddocument de 6 observations

13,4 yearsAmong HIV-positive women, PhenoAge acceleration (PhenoAA) was on average 13.4 years higher in women with invasive cervical cancer compared to cancer-free women.

Nigeriacancer du col de l'utérus · VIH/sidapublié 2022Frontiers in public healthPubMeddocument de 4 observations

88,93 GyThe mean dose to D90 of the HR-CTV was 88.93 ± 4.20 Gy in Group B patients.

Nigeriacancer du col de l'utéruspublié 2025BrachytherapyPubMeddocument de 8 observations

60,8 %The primary case finder screening sensitivity was 60.8% using gynaecologist review as confirmatory test.

Nigeriacancer du col de l'utérusobservé October 2020 to July 2021publié 2023Reproductive healthPubMeddocument de 9 observations

4,5 %4.5% of respondents were aware that HPV infection is a causative factor for cervical cancer in a community health outreach program in Ituku, Enugu State, Nigeria.

Nigeriacancer du col de l'utérus · infection à HPVobservé 2024publié 2026Rural and remote healthPubMeddocument de 8 observations

41,9 %Less than half (41.9%) of the female secondary school teachers in Enugu metropolis had good knowledge of the cervical cancer vaccine.

Nigeriacancer du col de l'utérusobservé 2017publié 2021The Pan African medical journalPubMeddocument de 7 observations

27,3 %Cervical cancer accounted for 66 cases (27.3%) among 242 gynecological cancer cases at Federal University Teaching Hospital, Owerri, from January 2020 to November 2022.

Nigeriacancer du col de l'utérusobservé January 2020 to November 2022publié 2023The Pan African medical journalPubMeddocument de 8 observations

66,5 %Post-intervention, knowledge of cervical cancer symptoms increased to 66.5% in the intervention group.

Nigeriacancer du col de l'utéruspublié 2022West African journal of medicinePubMeddocument de 12 observations

41,7 %41.7% of rural women in North Central Nigeria had fair/good consolidated knowledge of cervical cancer.

Nigeriacancer du col de l'utéruspublié 2026Rural and remote healthPubMeddocument de 21 observations

71,5 %The primary case finder screening specificity was 71.5% using gynaecologist review as confirmatory test.

Nigeriacancer du col de l'utérusobservé October 2020 to July 2021publié 2023Reproductive healthPubMeddocument de 9 observations

69,7 %69.7% of the women cited lack of knowledge of where to go for cervical cancer screening as a reason for not being screened.

Nigeriacancer du col de l'utéruspublié 2021The Pan African medical journalPubMeddocument de 8 observations

88 %88.0% of women in Taraba, North-East Nigeria had appropriate knowledge about the risk factors of cervical cancer.

Nigeriacancer du col de l'utéruspublié 2019Asian Pacific journal of cancer prevention : APJCPPubMeddocument de 6 observations

2 800 women2,800 women had more than one cervical cancer screening visit between 2006 and 2016 at Jos University Teaching Hospital in Nigeria.

Nigeriacancer du col de l'utérusobservé 2006–2016publié 2024Cancer causes & control : CCCPubMeddocument de 5 observations

32,4 %32.4% of the respondents were cervical cancer patients.

Nigeriacancer du col de l'utéruspublié 2026BMC women's healthPubMeddocument de 6 observations

26 %Comorbidity affects about 26% of cervical cancer patients in Nigeria.

Nigeriacancer du col de l'utéruspublié 2025International healthPubMeddocument de 2 observations